Related Experiment Video
Updated: Jul 5, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents
Eun Lee1, Kyunghoon Kim2, You Hoon Jeon3
1Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Insights
This study provides evidence-based guidelines for managing non-cystic fibrosis bronchiectasis in children. It addresses treatment and prevention of exacerbations, crucial for improving outcomes in pediatric respiratory illness.
Area of Science:
- Pediatric Respiratory Medicine
- Clinical Guidelines Development
Background:
- Non-cystic fibrosis bronchiectasis (NCFB) is a chronic respiratory condition with significant health and economic impacts.
- Effective management of NCFB requires early recognition and proactive treatment/prevention of exacerbations.
- Limited evidence exists for NCFB exacerbation management, particularly in pediatric populations.
Purpose of the Study:
- To develop evidence- and consensus-based guidelines for NCFB treatment in children and adolescents.
- To provide recommendations for medical and non-medical management strategies.
- To address critical aspects of NCFB care, including antibiotic use and airway clearance.
Main Methods:
- Utilized methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group.
- Systematic review of evidence published up to July 2, 2020.
- Incorporated expert opinions to supplement evidence where limited.
Main Results:
- Established comprehensive guidelines for pediatric NCFB management.
- Provided recommendations on antibiotic therapy and airway clearance techniques.
- Highlighted areas with limited evidence requiring further research.
Conclusions:
- The developed guidelines offer crucial support for clinicians managing NCFB in children and adolescents.
- Further large-scale, well-designed studies are needed to strengthen evidence-based management strategies.
- These guidelines aim to improve clinical outcomes for pediatric patients with NCFB.
Abstract:
Noncystic fibrosis bronchiectasis is a chronic respiratory disease that carries high socioeconomic and medical burdens and is caused by diverse respiratory illnesses. To improve clinical outcomes, early recognition, active treatment of exacerbations, and prevention of further exacerbations are essential. However, evidence for the treatment and prevention of acute exacerbation of noncystic fibrosis bronchiectasis, especially in children, is lacking. Therefore, the evidence- and consensus-based guidelines for medical and nonmedical treatment strategies for noncystic fibrosis bronchiectasis in children and adolescents were developed by the Korean Academy of Pediatric Allergy and Respiratory Disease using the methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation working group with evidence published through July 2, 2020. This guideline encompasses evidence-based treatment recommendations as well as expert opinions, addressing crucial aspects of the treatment and management of non-cystic fibrosis bronchiectasis in children. This includes considerations for antibiotics and airway clearance strategies, particularly in areas where evidence may be limited. Large, well-designed, and controlled studies are required to accumulate further evidence of management strategies for noncystic fibrosis bronchiectasis in children and adolescents.
More Related Videos
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...